![medtronic dorsal column stimulators medtronic dorsal column stimulators](https://m.psecn.photoshelter.com/img-get/I0000SaiZd5YeBHg/s/600/600/prn85306DS.jpg)
![medtronic dorsal column stimulators medtronic dorsal column stimulators](http://blog-imgs-46.fc2.com/k/e/n/kenjiyachiku/10-28-10-leadlesspacemaker8002.jpg)
“This can compromise the patient´s experience and therapeutic effectiveness. “Today, fixed-output spinal cord stimulation does not account for patient movements, which can alter the distance between the spinal cord and implanted epidural leads,” said Dirk Rasche, M.D., from the Department of Neurosurgery, University Hospital of Schleswig-Holstein in Lübeck, Germany. This is done seamlessly to provide consistent therapy while patients perform a full range of daily activities. As neural response decreases, stimulation returns to the pre-set optimal level. When neural response increases, such as when the patient coughs, sneezes, or bends, Inceptiv automatically decreases stimulation. By contrast, Inceptiv is able to sense the body’s neural response to stimulation 50 times per second, every second of every day. This in turn may lead some patients to turn down their device’s stimulation output, resulting in a suboptimal therapy experience. As patients go about their daily lives, certain movements may result in uncomfortable stimulation. Spinal cord stimulators deliver mild electrical impulses to the spinal cord, which can disrupt pain signals before they reach the brain. It is the first Medtronic SCS device to offer a closed-loop feature that senses each person’s unique biological signals and adjusts stimulation moment to moment, as needed, to keep therapy in harmony with the motions of daily life. Medtronic plc has received CE (Conformité Européenne) Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS).